This Week in Cardiology — Jun 15, 2026

Welcome to This Week in Cardiology. This week we're covering 9 notable papers spanning interventional cardiology and device updates, strategies for optimizing medical therapy and risk stratification, and a look at managing special populations with un… This week's papers: 1. Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association. — Circulation 2026 2. Randomized Controlled Trial of Internet-Delivered Cognitive Behavioral Therapy After Myocardial Infarction With Nonobstructive Coronary Arteries or Takotsubo S… — Journal of the American Heart Association 2026 3. Three-Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN-ON MED. — Journal of the American Heart Association 2026 4. Optimal Antithrombotic Therapy for Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis. — Journal of the American Heart Association 2026 5. Sex Differences in Clinical Outcomes and Loss of Life Expectancy After Aortic Valve Surgery for Infective Endocarditis: A SWEDEHEART Study. — Journal of the American Heart Association 2026 6. Great debate: surgical aortic valve replacement is first choice for aortic stenosis in patients with a life expectancy beyond 5 years. — European heart journal 2026 7. Cholesterol-lowering therapy from childhood/adolescence and long-term outcomes in familial hypercholesterolaemia: the SAFEHEART study. — European heart journal 2026 8. Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Lab… — Circulation 2026 9. Albuminuria and heart failure. — European heart journal 2026 Listen at https://audioscholar.cc/episode/ege3j957nc